retatrutide weight loss results clinical trials VisualAbstract: reduces body by 17.5% in patients with obesity Retatrutide: For the First Time

A GLP-1 Medicare Bridge programme launching on 1 July 2026 aims to set a net price of $245 per 30-day supply for participating manufacturers, representing a significant step toward broader access

Most gastrointestinal side effects resolve by week 12, leaving minimal symptoms during months 4-11

On raw Phase 3 efficacy numbers, yes 28.7% vs

So who tried this

Direct effects GLP-1R mRNA and protein have been detected in human renal vascular smooth muscle cells of afferent and efferent arterioles, interlobular and arcuate arteries, and juxtaglomerular and proximal tubular cells [56]

it resulted from the continuous activation of the GLP1 pathway